Aussie medicinal cannabis company Montu wins Deloitte’s Tech Fast 50

Christopher Strauch, Founder and Managing Director at Montu

Australia’s fastest-growing medicinal cannabis company Montu has placed #1 in Deloitte‘s Technology Fast 50 awards as it continues its meteoric rise with 20,728% growth in revenue over three years (2020-22). The firm conducts 50,000 over consultations annually, helping Aussies to receive access to life-changing medication with its patient-centric approach.

Deloitte’s Tech Fast 50 recognises the most successful and fastest growing Australian technology companies based on their revenue growth rates over the past three years. Montu’s Compound Annual Growth Rate (CAGR) for FY 20-22 was 1,343%, with revenue climbing to almost $22m in the last financial year. Montu is leading the market by making medicinal cannabis accessible and affordable to Australians with chronic medical conditions.

How integral has Montu been to its patients?

Patients use the integrated telehealth platform alternaleaf to consult with registered nurses and qualified doctors – all from the comfort of their homes. The company’s clinical team provides patients with individualised care and alternative treatments for a range of chronic conditions, including chronic pain, anxiety, insomnia, and depression, to name a few.

Adam Knightley who suffered a back injury after a tackle in football, was prescribed painkillers which left him depressed. It was only through medicinal cannabis that he found relief and was able to lead a normal life. “After my injury, I struggled to get through the day with my crippling back pain and the depression this led to after I had to quit the sport I loved,” he said.

“My weight ballooned to 187 kilos at one stage because I no longer wanted to leave the house. It was only after I was prescribed medicinal cannabis that my life changed and that heavy feeling was lifted. Now I want to share my story to help others,” Adam added.

Dr Parul Agarwal, MD, has been a doctor for the past 18 years and became an authorised medicinal cannabis prescriber two years ago after seeing a significant improvement in her patients with chronic pain. “I started to prescribe medicinal cannabis as my patients were looking for natural remedies, especially cancer patients who needed help with chronic pain.”

“I found that it worked beautifully for chronic pain, anxiety, depression, PTSD, ADHD and insomnia. I have seen how it has given my patients a better quality of life. I believe this is the beginning of how we perceive alternative medicine,” Dr Parul Agarwal further commented.

What does medicinal cannabis mean for healthcare?

When medicinal marijuana was legalised in 2016, a resounding 85% of Australians supported using cannabis for medicinal use. To date, there have been over 300,000 patient approvals by the TGA for various conditions, including chronic pain, anxiety, sleep disorders and ADHD.

Managing Director Christopher Strauch founded Montu with the mission to provide patients with an alternative to conventional medication and help millions of people live better lives. “The legalisation of medicinal cannabis marks a new chapter for the healthcare and wellness industry. We are proud to be leading this movement as it gives Aussies a powerful alternative to traditional medications and allows us to create a new standard in patient care,” he said.

“Our ongoing growth is a result of our patient-centric approach and streamlined process, which gives patients access to a natural plant-based alternative to manage their chronic conditions. Our focus is to provide the best care and outcomes for our patients so they can experience the many benefits of medicinal cannabis when used and administered correctly.”

Today, Montu has become a market leader in the emerging medical cannabis industry, providing an end-to-end ecosystem, from doctor education, clinical care, product supply and distribution to dispensing of medication. Its leading Australian online platform alternaleaf provides access to qualified doctors trained in prescribing medicinal cannabis.